Letybo, an acetylcholine release inhibitor and a neuromuscular blocking agent, was approved in March 2024 based on data from three phase 3 trials.

Hyporeflexia is the reduction or absence of the body's normal reflexes. It is caused by the disruptions of signals from nerve cells of the spinal cord (called motor neurons) to skeletal muscles that ...

This pitcher has super fast reflexes.